Filter
5124
Filtered Results: 5124
Text search:
National
Istitute
for
Health
Research
Featured
Recommendations
372
New Publications
1272
Language
Document type
No document type
2889
Studies & Reports
1085
Guidelines
541
Manuals
245
Strategic & Response Plan
145
Training Material
83
Fact sheets
75
Situation Updates
28
Resource Platforms
16
Brochures
8
Infographics
6
Online Courses
2
App
1
Countries / Regions
India
299
Global
219
Kenya
158
Ethiopia
139
Uganda
109
Western and Central Europe
104
Liberia
99
South Africa
96
Nigeria
92
Nepal
85
Latin America and the Carribbean
84
Bangladesh
82
Rwanda
80
Africa
79
Myanmar / Burma
68
Ghana
67
Tanzania
67
Sierra Leone
63
Zambia
61
Malawi
61
Ukraine
51
Philippines
49
Congo, Democratic Republic of
47
Syria
45
Cambodia
44
Eastern Europe
42
Mozambique
39
Asia
38
Brazil
37
Namibia
36
Indonesia
35
South–East Asia Region
33
Russia
31
Guinea
28
South Sudan
27
Zimbabwe
26
West and Central Africa
25
Germany
24
Burkina Faso
23
Haiti
23
East and Southern Africa
23
Pakistan
22
Afghanistan
19
Senegal
18
USA
18
Thailand
18
Colombia
16
Botswana
16
Lesotho
16
Middle East and North Africa
15
Vietnam
15
Yemen
14
Venezuela
14
Cameroon
13
Sudan
12
Eastern Europe and Central Asia
12
Somalia
11
Lebanon
11
China
11
Angola
11
Jordan
10
Peru
10
Western Pacific Region
10
Albania
10
Mali
9
Benin
9
Eswatini/ Swaziland
9
Tajikistan
9
Moldova
9
Iraq
8
Turkey
8
Central African Republic
8
North Macedonia
8
Côte d’Ivoire / Ivory Coast
7
Argentina
7
Chile
7
Laos
7
Iran
7
Papua New Guinea
6
Southern Africa
6
Libya
5
Mexico
5
Paraguay
5
Estonia
5
Kyrgyzstan
5
North America
5
United Kingdom
5
Portugal
5
Spain
5
Guinea-Bissau
4
Chad
4
Ecuador
4
Sri Lanka
4
Poland
4
Kazakhstan
4
Turkmenistan
4
Egypt
3
Malaysia
3
Serbia
3
Hungary
3
Madagascar
3
Bhutan
3
Italy
3
Armenia
3
Romania
3
Georgia
3
Jamaica
3
Japan
3
Mauritius
3
Bosnia and Herzegovina
3
Morocco
2
Saudi Arabia
2
Niger
2
Croatia
2
El Salvador
2
Greece
2
Palestine
2
Canada
2
Qatar
2
France
2
Tunisia
2
Belarus
2
Togo
1
Gambia
1
Mauritania
1
Singapore
1
Vanuatu
1
Burundi
1
Honduras
1
Bolivia
1
Guatemala
1
Other region
1
Solomon Islands
1
North Korea
1
Djibouti
1
Timor Leste/ East Timor
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
Azerbaijan
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1895
Clinical Guidelines
368
Public Health
319
Women & Child Health
220
Key Resources
199
Capacity Building
60
Pharmacy & Technologies
58
Annual Report MEDBOX
1
General Guidelines
1
Toolboxes
Mental Health
533
HIV
361
COVID-19
358
Planetary Health
298
TB
282
Disability
205
AMR
157
NTDs
142
Caregiver
134
Rapid Response
128
NCDs
128
Global Health Education
123
Ebola
114
Refugee
79
Conflict
77
Pharmacy
73
Health Financing Toolbox
64
Natural Hazards
47
Specific Hazards
31
Zika
26
Polio
20
Social Ethics
18
Cholera
14
South Sudan
2
Typhoon
1
Health Financing
1
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Guidelines for national programmes and other stakeholders
世界卫生组织 结核菌/艾滋病病毒双 重感染防治政策指南
——适用于国家规划 和利益攸关方
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
We combine data on Chinese development projects with data from Demographic and Health Surveys to study the impact of Chinese aid on household welfare in sub-Saharan Africa. We use a novel methodology to test the effect of Chinese aid on three import...
This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions expressed are t...
Induced abortion is permitted in Burkina Faso only to save the life and protect the health of a
pregnant woman, or in cases of rape, incest, and severe fetal impairment. As a result, the vast
majority of women who end unintended pregnancies do so ...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
A manual for physicians and other senior health workers. This fourth revision of the manual reflects recent clinical experience and research findin...
The primary audience for these recommendations includes health professionals who are responsible for developing ... and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this includes midwives, nurses, general medical practitioners and obstetricians. The primary audience also includes managers of maternal and child health programmes, and relevant staff in ministries of health and educational and training institutions, in all settings.
Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of ...
Charting a Path to Achieve Health Equity. The decade ahead will test the nation's nearly 4 million nurses in new and complex ways. Nurses live and work at the intersection of health, education, and ...
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group al...
The purpose of the PAS III is to guide Pakistan’s overall national response for HIV and AIDS through 2020, through focused interventions with set targets, costs, roles and responsibilities. The su...
This Framework offers a coherent approach for eliminating tuberculosis (TB) in low-incidence countries. It is designed to guide national policy-makers and those responsible ... technical aspects of the national TB response in accelerating efforts towards elimination. The document will also be informative for public health surveillance officers, practitioners and nongovernmental and civil society partners working on natioal TB care and prevention and serving the populations most vulnerable to TB.
Evidence from a systematic review on antenatal zinc supplementation was evaluated as part of the World Health Organization (WHO) antenatal care (ANC) guideline development process in 2016, and the following recommendation on zinc supplementation was...
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are need...
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-e...
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. More...
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity syst...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept fo... research. The first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
